Biopharma VC Funding Fell in Q3, Scrip Reports
Biopharma venture investment fell in Q3, Scrip reports, but the analysis still projects full-year 2026 growth, leaving the sector's fundraising trend intact.
Topic
Topic
Biopharma venture investment fell in Q3, Scrip reports, but the analysis still projects full-year 2026 growth, leaving the sector's fundraising trend intact.
Funding for cybersecurity startups climbed in the third quarter, The Wall Street Journal reports, signaling renewed venture appet…
Venture funding fell in the third quarter to a more "muted" level, the San Francisco Examiner reports, signaling tighter discipli…